Drug Price Trends for NDC 83324-0122

Average Pharmacy Cost for 83324-0122

Drug Name	NDC	Price/Unit ($)	Unit	Date
QC ANTACID-ANTIGAS MAX STR LIQ	83324-0122-12	0.01161	ML	2025-02-19
QC ANTACID-ANTIGAS MAX STR LIQ	83324-0122-12	0.01142	ML	2025-02-05

Best Wholesale Price for NDC 83324-0122

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 83324-0122

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing a crucial role in shaping the healthcare landscape. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug identified by National Drug Code (NDC) 83324-0122. By examining various factors influencing drug pricing and market behavior, we aim to provide valuable insights for industry professionals, healthcare providers, and consumers alike.

Understanding NDC 83324-0122

The National Drug Code (NDC) is a unique identifier assigned to human drugs in the United States. NDC 83324-0122 represents a specific drug product, and understanding its market position requires a closer look at its characteristics and the broader pharmaceutical landscape.

What is an NDC?

The NDC is a three-segment number that serves as a universal product identifier for drugs[4]. It consists of:

1. The labeler code (assigned by the FDA)
2. The product code (assigned by the manufacturer)
3. The package code (assigned by the manufacturer)

This unique code allows for precise identification and tracking of drug products throughout the supply chain.

Identifying the Drug

While the search results don't provide specific information about the drug associated with NDC 83324-0122, we can infer that it belongs to a product line from the same manufacturer as NDC 83324-0112, which is identified as "QC HEAD CONGEST-MUCUS PE CPLT"[2]. This suggests that NDC 83324-0122 might be a related product or a different formulation within the same therapeutic category.

Current Market Trends in Pharmaceuticals

To understand the potential market trajectory of NDC 83324-0122, it's essential to examine the broader trends affecting the pharmaceutical industry.

Overall Drug Price Inflation

Recent projections indicate a significant upward trend in drug prices:

According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate is projected to be around 3.8% for the period from July 1, 2024, to June 30, 2025[1].

This increase is primarily driven by specialty pharmaceuticals, which include high-cost, complex, or chronic condition treatments.

Specialty Pharmaceuticals

Specialty drugs are expected to see an even higher price increase of 4.18%[1]. These medications often treat conditions such as:

• Cancer
• Infectious diseases
• Autoimmune disorders
• Pulmonary conditions

The increasing utilization of these drugs and the anticipated expansion of gene therapies contribute significantly to the projected price increase.

Factors Influencing Drug Pricing

Several key factors play a role in determining drug prices and market dynamics:

Supply Chain Complexity

The pharmaceutical supply chain involves multiple stakeholders, including manufacturers, wholesalers, pharmacy benefit managers (PBMs), and retailers. Each entity in this chain can influence the final price of a drug.

Regulatory Environment

Government policies and regulations significantly impact drug pricing. For instance, the implementation of upper payment limits in some states could affect the pricing of high-cost medications[2].

Market Competition

The presence of generic alternatives and biosimilars can exert downward pressure on drug prices. For example:

The introduction of biosimilars for drugs like Enbrel (etanercept) has led to increased competition and potentially lower prices[2].

Research and Development Costs

Pharmaceutical companies often justify high drug prices by citing the substantial investments required for drug development and clinical trials.

Price Projections for NDC 83324-0122

While specific price data for NDC 83324-0122 is not available in the search results, we can make informed projections based on industry trends and related products.

Short-term Outlook

Given the overall projected drug price inflation of 3.8%, it's reasonable to expect that NDC 83324-0122 may see a similar increase in price over the next year, assuming it follows general market trends.

Long-term Considerations

Several factors could influence the long-term pricing of NDC 83324-0122:

1. Patent Status: If the drug is still under patent protection, it may maintain higher prices until generic competition enters the market.
2. Therapeutic Category: The specific medical condition treated by the drug will impact its pricing trajectory.
3. Manufacturing Costs: Changes in production costs or supply chain disruptions could affect pricing.
4. Policy Changes: Potential healthcare reforms or changes in drug pricing policies could significantly impact future prices.

Impact on Stakeholders

The pricing and market dynamics of NDC 83324-0122 will have varying effects on different stakeholders in the healthcare ecosystem.

Healthcare Providers

Hospitals and clinics may face challenges in managing pharmacy expenditures due to rising drug costs. This could lead to:

• Increased focus on cost-effective prescribing practices
• Negotiations with suppliers for better pricing
• Implementation of more robust inventory management systems

Patients and Consumers

The ultimate impact of drug pricing falls on patients. Higher prices can lead to:

• Increased out-of-pocket expenses
• Potential medication non-adherence due to cost
• Greater reliance on patient assistance programs

Insurers and PBMs

These entities will likely respond to price increases by:

• Adjusting formularies to favor more cost-effective options
• Implementing stricter prior authorization requirements
• Negotiating rebates and discounts with manufacturers

Strategies for Market Success

For pharmaceutical companies and healthcare providers, several strategies can help navigate the evolving market landscape:

1. Data-Driven Decision Making: Utilize market analytics to inform pricing and distribution strategies.
2. Value-Based Pricing: Consider outcomes-based pricing models that tie drug costs to patient results.
3. Supply Chain Optimization: Invest in technologies that improve efficiency and reduce costs throughout the supply chain.
4. Patient Support Programs: Develop comprehensive programs to assist patients with access and affordability.
5. Regulatory Engagement: Actively participate in policy discussions to shape a favorable regulatory environment.

Future Outlook

The pharmaceutical market is poised for continued evolution, with several trends likely to shape the future:

Personalized Medicine

Advancements in genomics and precision medicine may lead to more targeted therapies, potentially affecting pricing models for drugs like NDC 83324-0122.

Digital Health Integration

The integration of digital health technologies could improve drug efficacy tracking and potentially influence pricing based on real-world outcomes.

Global Market Dynamics

International price comparisons and global supply chain considerations will play an increasingly important role in domestic pricing strategies.

Key Takeaways

• The pharmaceutical industry is experiencing overall drug price inflation, with projections indicating a 3.8% increase for 2024-2025.
• Specialty pharmaceuticals are driving much of this increase, with an expected 4.18% rise in prices.
• NDC 83324-0122, while not specifically detailed in the search results, is likely to be influenced by these broader market trends.
• Factors such as supply chain complexity, regulatory environment, and market competition significantly impact drug pricing.
• Stakeholders across the healthcare ecosystem, including providers, patients, and insurers, will need to adapt to these changing market dynamics.
• Successful navigation of the pharmaceutical market requires data-driven strategies, value-based approaches, and active engagement with regulatory processes.
• The future of drug pricing and market analysis will be shaped by advancements in personalized medicine, digital health integration, and global market considerations.

FAQs

1. What is the significance of an NDC number in pharmaceutical market analysis? An NDC number is a unique identifier that allows for precise tracking and analysis of specific drug products, enabling accurate market assessments and price comparisons.

2. How do specialty pharmaceuticals impact overall drug price trends? Specialty pharmaceuticals, which often have high price tags and treat complex conditions, are a major driver of drug price inflation, with projections showing a 4.18% increase compared to the overall 3.8% for all drugs.

3. What role do biosimilars play in drug pricing? Biosimilars can introduce competition to the market for biologic drugs, potentially leading to lower prices for both the original drug and its biosimilar counterparts.

4. How might future technological advancements affect drug pricing strategies? Advancements in personalized medicine and digital health technologies may lead to more targeted therapies and outcomes-based pricing models, potentially reshaping traditional drug pricing strategies.

5. What can healthcare providers do to manage rising drug costs? Healthcare providers can focus on cost-effective prescribing practices, negotiate with suppliers, implement robust inventory management systems, and engage in value-based care initiatives to manage rising drug costs.

Sources cited: [1] https://qualitysmartsolutions.com/blog/why-ndc-numbers-are-vital-for-pharmaceutical-companies/ [2] https://www.drugpatentwatch.com/p/drug-price/ndc/83324-0112 [4] https://en.wikipedia.org/wiki/National_drug_code